Prime Medicine
A Scientist II at Prime Medicine supports BLA activities for a cell therapy program, overseeing process validation and clinical manufacturing oversight at a CDMO partner. The role involves technical documentation for regulatory submissions and collaboration across teams to ensure product licensure.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2019
Prime Medicine is a biotechnology company translating Prime Editing — a CRISPR-derived, “search-and-replace” genome‑editing technology that makes precise DNA changes without double‑strand breaks — into therapeutic medicines. The company develops optimized prime editors, guide RNAs and delivery systems to correct disease‑causing mutations across in vivo and ex vivo indications, with programs targeting genetic diseases in blood, liver and other tissues. Headquartered in Cambridge, MA and founded by leaders in genome editing, Prime Medicine is advancing a pipeline of discovery and preclinical programs and partnering to move therapies toward the clinic.
Prime Medicine (PRME) Focuses on Liver Franchise With $191.4M Cash Runway
5 days ago
Asked and Answered: Prime Medicine CEO on First Prime Editing Patient Data
Dec 18, 2025
Prime Medicine (NYSE:PRME) Earns Outperform Rating from Analysts at Oppenheimer
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Prime Medicine.
6% above the average for this role
Prime to test FDA flexibility with 2-patient gene editing submission
1 week ago
Senior Research Associate, Process Development, Cell Therapy
Resilience
Research Associate in Cell Biology
colossalbiosciences.com
Scientist , Cell Therapy -FSP
Parexel
CAR-T Manufacturing Process Development Scientist
AstraZeneca
Analytical Development Scientist - Cell Therapy
Capricor Therapeutics
Director, Immunology Cell Therapy Discovery
AstraZeneca